Abstract
This report describes the development of novel benzamides which are orally active, highly potent, specific antagonists of 5-HT3 receptors. Described in this first report are the structure-activity relationships that led to novel structures with improved potency and selectivity. From this series of compounds, (S)-28 was identified and selected for further evaluation as a 5-HT3 receptor antagonist. Compared with 5-HT3 antagonists such as GR 38032F, BRL 43694, and metoclopramide, (S)-28 was most active in (a) inhibiting binding to 5-HT3 receptor binding sites in rat entorhinal cortex with an Ki value of 0.19 nM and (b) blocking cisplatin-induced emesis in the ferret with an ED50 value determined to be 9 micrograms/kg po.
MeSH terms
-
Animals
-
Antiemetics / chemical synthesis*
-
Antiemetics / pharmacology
-
Antiemetics / therapeutic use
-
Benzamides / chemical synthesis*
-
Benzamides / pharmacology
-
Benzamides / therapeutic use
-
Benzofurans / chemical synthesis*
-
Benzofurans / pharmacology
-
Benzofurans / therapeutic use
-
Binding, Competitive
-
Bridged Bicyclo Compounds / chemical synthesis*
-
Bridged Bicyclo Compounds / pharmacology
-
Bridged Bicyclo Compounds / therapeutic use
-
Bridged Bicyclo Compounds, Heterocyclic*
-
Cerebral Cortex / metabolism
-
Cisplatin / toxicity
-
Ferrets
-
Granisetron
-
Imidazoles / metabolism
-
Imidazoles / pharmacology
-
Imidazoles / therapeutic use
-
Indazoles / pharmacology
-
Indazoles / therapeutic use
-
Indoles / metabolism
-
Male
-
Metoclopramide / pharmacology
-
Metoclopramide / therapeutic use
-
Molecular Structure
-
Ondansetron
-
Rats
-
Receptors, Serotonin / metabolism
-
Serotonin Antagonists*
-
Structure-Activity Relationship
-
Vomiting / chemically induced
-
Vomiting / prevention & control
Substances
-
Antiemetics
-
Benzamides
-
Benzofurans
-
Bridged Bicyclo Compounds
-
Bridged Bicyclo Compounds, Heterocyclic
-
Imidazoles
-
Indazoles
-
Indoles
-
Receptors, Serotonin
-
Serotonin Antagonists
-
GR 65630
-
N-(1-azabicyclo(2.2.2)-oct-3-yl)-5-chlorospiro(benzofuran-2(3H),1'-cyclohexane)-7-carboxamide
-
Ondansetron
-
Metoclopramide
-
Cisplatin
-
Granisetron